AbCellera Biologics (ABCL) Retained Earnings (2020 - 2026)
AbCellera Biologics (ABCL) posted Retained Earnings of -$2.4 million for Q1 2026, up 91.79% on a QoQ basis from -$29.5 million in Q4 2025, and up 65.43% year-over-year from -$1.5 million in Q1 2025.
AbCellera Biologics (ABCL) Retained Earnings (2020 - 2026) Analysis & Trends
AbCellera Biologics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- Quarterly Retained Earnings rose 65.43% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (up 65.43% YoY) and the FY2025 annual result came in at -$29.5 million, down 573.41% from the prior year.
- Retained Earnings was -$2.4 million for Q1 2026 at AbCellera Biologics, up from -$29.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at $436.2 million in Q1 2022 and bottomed at -$29.5 million in Q4 2025.
- A 5-year average of $96.8 million and a median of -$1.5 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 596.79% — and 2023, when it surged 20214.09%.
- AbCellera Biologics' Retained Earnings stood at -$1.4 million in 2022, then soared by 20214.09% to $279.8 million in 2023, then tumbled by 101.56% to -$4.4 million in 2024, then plunged by 573.41% to -$29.5 million in 2025, then surged by 91.79% to -$2.4 million in 2026.
- Business Quant data shows ABCL's Retained Earnings at -$2.4 million in Q1 2026, -$29.5 million in Q4 2025, and -$20.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -2.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.42 Mn |
| Dec 31, 2025 | -29.48 Mn |
| Sep 30, 2025 | -20.54 Mn |
| Jun 30, 2025 | 36.58 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | -4.38 Mn |
| Sep 30, 2024 | 151.14 Mn |
| Jun 30, 2024 | -2.07 Mn |
| Mar 31, 2024 | -1.82 Mn |
| Dec 31, 2023 | 279.79 Mn |
| Sep 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | -1.90 Mn |
| Mar 31, 2023 | 386.08 Mn |
| Dec 31, 2022 | -1.39 Mn |
| Sep 30, 2022 | -717,000.00 |
| Jun 30, 2022 | 429.45 Mn |
| Mar 31, 2022 | 436.24 Mn |
| Dec 31, 2021 | 280,000.00 |
| Sep 30, 2021 | 207.72 Mn |
| Jun 30, 2021 | 2.15 Mn |